Showing results (21-30 of 106) with videos related to
Sort By:
Pageof 11
Der Nervenarzt|April 18, 2018
[Diagnostics and conservative treatment of cervical and lumbar spinal stenosis]A Hug, S Hähnel, N WeidnerFrontiers in Microbiology|February 19, 2015
Corrigendum: Diversity of reductive dehalogenase genes from environmental samples and enrichment cultures identified with degenerate primer PCR screensLaura A Hug, Elizabeth A EdwardsFrontiers in Microbiology|December 7, 2013
Diversity of reductive dehalogenase genes from environmental samples and enrichment cultures identified with degenerate primer PCR screensLaura A Hug, Elizabeth A EdwardsPhilosophical Transactions of the Royal Society of London. Series B, Biological Sciences|August 7, 2025
The evolution of the tree of lifeMolly Chen, Artem I Kholodov, Laura A HugJournal of Veterinary Emergency and Critical Care (San Antonio, Tex. : 2001)|July 18, 2013
Evaluation of a continuous glucose monitoring system compared with an in-house standard laboratory assay and a handheld point-of-care glucometer in critically ill neonatal foalsSophie A Hug, Barbara Riond, Colin C SchwarzwaldMolecular Biology and Evolution|October 7, 2009
Phylogenetic distributions and histories of proteins involved in anaerobic pyruvate metabolism in eukaryotesLaura A Hug, Alexandra Stechmann, Andrew J RogerNucleic Acids Research|November 11, 1992
Structure and function of the murine beta-globin locus control region 5' HS-3B A Hug, A M Moon, T J LeyInternational Journal of Cancer|November 9, 2011
A randomized, crossover, placebo- and moxifloxacin-controlled study to evaluate the effects of bosutinib (SKI-606), a dual Src/Abl tyrosine kinase inhibitor, on cardiac repolarization in healthy adult subjectsRichat Abbas, Bruce A Hug, Cathie Leister, et al.Nature Communications|November 17, 2023
Microbial methane cycling in a landfill on a decadal time scaleDaniel S Grégoire, Nikhil A George, Laura A HugCancer Chemotherapy and Pharmacology|March 16, 2012
A double-blind, randomized, multiple-dose, parallel-group study to characterize the occurrence of diarrhea following two different dosing regimens of neratinib, an irreversible pan-ErbB receptor tyrosine kinase inhibitorRichat Abbas, Bruce A Hug, Cathie Leister, et al.Pageof 11